Drug: PAXIL Injury: Disturbance in attention Quarter: 2016Q3
Total Records: 92 Number of Pages: 5
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125024562 | PAXIL | Disturbance in attention | APOTEX | 14.00 YR | F | 0 | 20160715 | GB |
125024822 | PAXIL | Disturbance in attention | APOTEX | 46.00 YR | F | 0 | 20160715 | GB |
125169642 | PAXIL | Disturbance in attention | MYLAN | 0.00 | 0 | 20160715 | GB | |
125177362 | PAXIL | Disturbance in attention | SANDOZ | 25.00 YR | F | 0 | 20160805 | GB |
125193473 | PAXIL | Disturbance in attention | TEVA | 63.00 YR | F | 0 | 20160818 | GB |
125211823 | PAXIL | Disturbance in attention | SANDOZ | 0.00 | 0 | 20160718 | GB | |
125216443 | PAXIL | Disturbance in attention | SANDOZ | 35.00 YR | M | 0 | 20160727 | GB |
125224322 | PAXIL | Disturbance in attention | MYLAN | 0.00 | 0 | 20160715 | GB | |
125245392 | PAXIL | Disturbance in attention | SANDOZ | 23.00 YR | M | 0 | 20160712 | GB |
125245421 | PAXIL | Disturbance in attention | SANDOZ | 42.00 YR | F | 0 | 20160704 | GB |
125245433 | PAXIL | Disturbance in attention | SANDOZ | 49.00 YR | M | 0 | 20160715 | GB |
125283521 | PAXIL | Disturbance in attention | SANDOZ | 0.00 | 0 | 20160705 | GB | |
125296642 | PAXIL | Disturbance in attention | AUROBINDO | 0.00 | 0 | 20160811 | GB | |
125317811 | PAXIL | Disturbance in attention | MYLAN | 0.00 | 0 | 20160706 | GB | |
125322181 | PAXIL | Disturbance in attention | MYLAN | 0.00 | 0 | 20160706 | GB | |
125353702 | PAXIL | Disturbance in attention | AUROBINDO | 0.00 | 0 | 20160811 | GB | |
125353722 | PAXIL | Disturbance in attention | AUROBINDO | 0.00 | 0 | 20160721 | GB | |
125356101 | PAXIL | Disturbance in attention | AUROBINDO | 0.00 | M | 0 | 20160707 | GB |
125361163 | PAXIL | Disturbance in attention | TEVA | 23.00 YR | M | 0 | 20160727 | GB |
125363701 | PAXIL | Disturbance in attention | TEVA | 42.00 YR | F | 0 | 20160707 | GB |
Total Records: 92 Number of Pages: 5